• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Dietary supplements – Market size and forecast 2020-2025
o Pharmaceuticals – Market size and forecast 2020-2025
o Cosmetics – Market size and forecast 2020-2025
o Market opportunity by Application
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Kaneka Corp.
o Kikkoman Corp.
o Kirin Holdings Co. Ltd.
o Koninklijke DSM NV
o Lesaffre and Cie
o Nisshin Seifun Group Inc.
o Otsuka Holdings Co. Ltd.
o Pharma Nord Inc.
o PharmaEssentia Corp.
o Zhejiang Medicine Co. Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Application – Market share 2020-2025 (%)
• 22: Comparison by Application
• 23: Dietary supplements – Market size and forecast 2020-2025 ($ million)
• 24: Dietary supplements – Year-over-year growth 2020-2025 (%)
• 25: Pharmaceuticals – Market size and forecast 2020-2025 ($ million)
• 26: Pharmaceuticals – Year-over-year growth 2020-2025 (%)
• 27: Cosmetics – Market size and forecast 2020-2025 ($ million)
• 28: Cosmetics – Year-over-year growth 2020-2025 (%)
• 29: Market opportunity by Application
• 30: Customer landscape
• 31: Market share By Geographical Landscape 2020-2025 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2020-2025 ($ million)
• 34: North America – Year-over-year growth 2020-2025 (%)
• 35: Europe – Market size and forecast 2020-2025 ($ million)
• 36: Europe – Year-over-year growth 2020-2025 (%)
• 37: Asia – Market size and forecast 2020-2025 ($ million)
• 38: Asia – Year-over-year growth 2020-2025 (%)
• 39: ROW – Market size and forecast 2020-2025 ($ million)
• 40: ROW – Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Kaneka Corp. – Overview
• 50: Kaneka Corp. – Business segments
• 51: Kaneka Corp. – Key offerings
• 52: Kaneka Corp. – Key customers
• 53: Kaneka Corp. – Segment focus
• 54: Kikkoman Corp. – Overview
• 55: Kikkoman Corp. – Business segments
• 56: Kikkoman Corp. – Key offerings
• 57: Kikkoman Corp. – Key customers
• 58: Kikkoman Corp. – Segment focus
• 59: Kirin Holdings Co. Ltd. – Overview
• 60: Kirin Holdings Co. Ltd. – Business segments
• 61: Kirin Holdings Co. Ltd. – Key offerings
• 62: Kirin Holdings Co. Ltd. – Key customers
• 63: Kirin Holdings Co. Ltd. – Segment focus
• 64: Koninklijke DSM NV – Overview
• 65: Koninklijke DSM NV – Business segments
• 66: Koninklijke DSM NV – Key offerings
• 67: Koninklijke DSM NV – Key customers
• 68: Koninklijke DSM NV – Segment focus
• 69: Lesaffre and Cie – Overview
• 70: Lesaffre and Cie – Product and service
• 71: Lesaffre and Cie – Key offerings
• 72: Lesaffre and Cie – Key customers
• 73: Lesaffre and Cie – Segment focus
• 74: Nisshin Seifun Group Inc. – Overview
• 75: Nisshin Seifun Group Inc. – Business segments
• 76: Nisshin Seifun Group Inc. – Key offerings
• 77: Nisshin Seifun Group Inc. – Key customers
• 78: Nisshin Seifun Group Inc. – Segment focus
• 79: Otsuka Holdings Co. Ltd. – Overview
• 80: Otsuka Holdings Co. Ltd. – Business segments
• 81: Otsuka Holdings Co. Ltd. – Key offerings
• 82: Otsuka Holdings Co. Ltd. – Key customers
• 83: Otsuka Holdings Co. Ltd. – Segment focus
• 84: Pharma Nord Inc. – Overview
• 85: Pharma Nord Inc. – Product and service
• 86: Pharma Nord Inc. – Key offerings
• 87: Pharma Nord Inc. – Key customers
• 88: Pharma Nord Inc. – Segment focus
• 89: PharmaEssentia Corp. – Overview
• 90: PharmaEssentia Corp. – Business segments
• 91: PharmaEssentia Corp. – Key offerings
• 92: PharmaEssentia Corp. – Key customers
• 93: PharmaEssentia Corp. – Segment focus
• 94: Zhejiang Medicine Co. Ltd. – Overview
• 95: Zhejiang Medicine Co. Ltd. – Product and service
• 96: Zhejiang Medicine Co. Ltd. – Key offerings
• 97: Zhejiang Medicine Co. Ltd. – Key customers
• 98: Zhejiang Medicine Co. Ltd. – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations
【掲載企業】
Kaneka Corp., Kikkoman Corp., Kirin Holdings Co. Ltd., Koninklijke DSM NV, Lesaffre and Cie, Nisshin Seifun Group Inc., Otsuka Holdings Co. Ltd., Pharma Nord Inc., PharmaEssentia Corp., Zhejiang Medicine Co. Ltd.
【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。